Understanding the Global Hingles Vaccine Market: An Overview - นิยาย Understanding the Global Hingles Vaccine Market: An Overview : Dek-D.com - Writer
×

    Understanding the Global Hingles Vaccine Market: An Overview

    ผู้เข้าชมรวม

    59

    ผู้เข้าชมเดือนนี้

    1

    ผู้เข้าชมรวม


    59

    ความคิดเห็น


    1

    คนติดตาม


    0
    หมวด :  รักอื่น ๆ
    จำนวนตอน :  0 ตอน
    อัปเดตล่าสุด :  28 ก.พ. 66 / 17:32 น.
    ตั้งค่าการอ่าน

    ค่าเริ่มต้น

    • เลื่อนอัตโนมัติ

    The shingles vaccine market refers to the market for vaccines that protect against shingles, a viral infection that causes a painful rash. The most common shingles vaccine is Zostavax, which was developed by Merck & Co. and was approved by the U.S. Food and Drug Administration (FDA) in 2006. In 2017, a new shingles vaccine called Shingrix, developed by GlaxoSmithKline (GSK), was approved by the FDA and is now available in many countries.

    The market growth is driven by increasing incidence of herpes zoster, the virus that causes shingles, especially among the aging population, and growing awareness about vaccination for preventing shingles.

    The market is segmented by type, distribution channel, and region. By type, the market is divided into live attenuated and subunit vaccines. By distribution channel, the market is divided into hospitals, clinics, pharmacies, and others.

    Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the market due to high demand for shingles vaccines, increasing incidence of herpes zoster, and presence of major market players.

    The key players operating in the shingles vaccine market include Merck & Co., GlaxoSmithKline plc, Sanofi Pasteur SA, Pfizer, Inc., and Seqirus Pty Ltd., among others. These companies are focusing on developing effective and safe shingles vaccines and expanding their distribution networks to increase their market share.

    In conclusion, the global shingles vaccine market is expected to grow in the coming years due to increasing incidence of herpes zoster and growing awareness about vaccination for preventing shingles. The market is segmented by type, distribution channel, and region, with North America expected to hold the largest market share. The key players in the market are investing in research and development to develop effective and safe vaccines and expanding their distribution networks to increase their market share.

    ผู้อ่านนิยมอ่านต่อ ดูทั้งหมด

    loading
    กำลังโหลด...

    อีบุ๊ก ดูทั้งหมด

    loading
    กำลังโหลด...

    ความคิดเห็น